Correlation Between Palantir Technologies and NervGen Pharma

Can any of the company-specific risk be diversified away by investing in both Palantir Technologies and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palantir Technologies and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Palantir Technologies Class and NervGen Pharma Corp, you can compare the effects of market volatilities on Palantir Technologies and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palantir Technologies with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palantir Technologies and NervGen Pharma.

Diversification Opportunities for Palantir Technologies and NervGen Pharma

-0.03

Correlation Coefficient

Palantir Technologies  NervGen Pharma

Good diversification

The 3 months correlation between Palantir and NervGen is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Palantir Technologies Class and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Palantir Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palantir Technologies Class are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Palantir Technologies i.e., Palantir Technologies and NervGen Pharma go up and down completely randomly.

Pair Corralation between Palantir Technologies and NervGen Pharma

Given the investment horizon of 90 days Palantir Technologies Class is expected to generate 2.96 times more return on investment than NervGen Pharma. However, Palantir Technologies is 2.96 times more volatile than NervGen Pharma Corp. It trades about 0.06 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about -0.13 per unit of risk. If you would invest  7,718  in Palantir Technologies Class on December 30, 2024 and sell it today you would earn a total of  867.00  from holding Palantir Technologies Class or generate 11.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Palantir Technologies Class  vs.  NervGen Pharma Corp

Palantir Technologies

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Palantir Technologies Class are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Palantir Technologies reported solid returns over the last few months and may actually be approaching a breakup point.

NervGen Pharma Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Palantir Technologies and NervGen Pharma

The main advantage of trading using opposite Palantir Technologies and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palantir Technologies position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.

The idea behind Palantir Technologies Class and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.